Family 10: Neurological and Thalamocortical
Family overview. CNS pathology in chronic disease ranges from neuroinflammation to circuit-level dysregulation of oscillatory dynamics, neurotransmitter balance, and structural integrity. The thalamocortical system gates sensory processing, sleep, attention, and arousal; its dysregulation produces a symptom cluster that crosses traditional diagnostic boundaries.
Concrete mechanisms and ME/CFS evidence:
Neuroinflammation (microglial activation). PET imaging with TSPO ligands (a validated microglial activation marker) shows increased neuroinflammation in brainstem, hippocampus, amygdala, and prefrontal cortex of ME/CFS patients (Nakatomi et al. 2014). Among the most direct CNS evidence in ME/CFS.
Excitation/inhibition (E/I) imbalance. Elevated glutamate in brain regions by MRS; insufficient GABAergic inhibition; proposed to drive cognitive impairment via excitotoxicity and to amplify neuroinflammation through glutamate-microglial crosstalk.
Thalamocortical hyperexcitability and alpha intrusion. Changes in thalamic reticular nucleus inhibitory signalling and in thalamic T-type calcium currents (I_T) and HCN currents (I_h) shift thalamocortical circuits from slow delta (restorative) to alpha (wake-like) oscillatory modes during NREM sleep (Timofeev and Bazhenov 2005). The result is alpha-wave intrusion into slow-wave sleep — waking brain oscillations contaminating restorative sleep at rates that impair glymphatic clearance and produce non-restorative sleep regardless of total sleep duration.
Glymphatic clearance failure. The glymphatic system — CSF flow driven by AQP4 water channels along perivascular spaces during slow-wave oscillations — clears metabolic waste including amyloid-β, tau, and lactate from brain parenchyma. Alpha-wave intrusion reduces the oscillatory driving force for this clearance, producing metabolic waste accumulation in CNS tissue. This mechanism directly links thalamocortical dysregulation to neuroinflammation and cognitive impairment.
Blood-brain barrier disruption. Increased BBB permeability documented in ME/CFS; bradykinin, cytokines, nitric oxide, and peroxynitrite are proposed permeability drivers. Peripheral immune cells gain CNS access, amplifying neuroinflammation (Natelson and Lange 2001).
Cerebral hypoperfusion (CNS expression). Cerebral hypoperfusion documented by SPECT and during orthostatic challenge; hypoxic CNS tissue upregulates PDK, further suppressing mitochondrial metabolism — a cerebral metabolic-vascular vicious cycle.
Cortical hypoactivation at rest. qEEG studies show increased theta at rest; peak alpha frequency inversely correlated with fatigue ratings — an underactivated brain expending disproportionate effort to maintain baseline function.
Full discussion: Neurological and Neurocognitive Dysfunction.
Evidence status: Established (neuroinflammation, E/I imbalance, and hypoperfusion independently replicated; thalamocortical/glymphatic mechanism well-characterised in fibromyalgia and sleep disorders, preliminary in ME/CFS specifically).